Sprint Corporation (NYSE:S)

Sprint Corporation offers communications services. It operates in two segments: Wireless and Wireline. It develops, engineers and deploys technologies, including wireless networks offering mobile data services, instant national and international push-to-talk capabilities and a global Tier 1 Internet backbone. Sprint Corporation is based in Overland Park, United States.

Sprint Corporation (NYSE:S)’s Financial Overview

Sprint Corporation (NYSE:S) surged 1.78% yesterday to close its trading session at $8. The company has 1 year Price Target of $7.28. Sprint Corporation has 52-Week high of $8.1 and 52-Week Low of $2.18. The stock touched its 52-Week High on Nov 28, 2016 and 52-Week Low on Jan 20, 2016. The stock traded with the volume of 18.2 Million shares yesterday. The firm shows the market capitalization of $31.85 Billion.

Sprint Corporation (NYSE:S) reported its last quarterly earnings on Mar 13 where the firm reported its Actual EPS of $-0.21/share against the analyst consensus estimate of $-0.33/share. The difference between the actual and expected EPS is $0.12 a share with a surprise factor of 36.4%.

The firm is trading with SMA20 of 13.87 Percent, SMA50 of 17.72 Percent and SMA200 of 60.11 percent. Sprint Corporation has P/S value of 0.98 while its P/B value stands at 1.64. Similarly, the company has Return on Assets of -2.3 percent, Return on Equity of -9.3 percent and Return on Investment of 0.3 Percent. The company shows Gross Margin and Operating Margin of 53.6 percent and 2.4 percent respectively.

Many brokerage firms are involved in issuing their ratings on Sprint Corporation (NYSE:S). On 25-Aug-16 Buckingham Research Downgrade Sprint Corporation Stock  to Underperform. Another firm also rated the stock on 26-Jul-16 where Pacific Crest Upgrade the stock to Sector Weight.

The Stock currently has Analyst’ mean Recommendation of 2.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 18 analysts offering 12-month price forecasts for Sprint Corp have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 2.20. The median estimate represents a -25.00% decrease from the last price of 8.00.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

TherapeuticsMD, Inc. (NYSEMKT:TXMD)

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.

TherapeuticsMD, Inc. (NYSEMKT:TXMD)’s Financial Outlook

The 5 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 14.00, with a high estimate of 33.00 and a low estimate of 10.50. The median estimate represents a +143.90% increase from the last price of 5.74.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, TherapeuticsMD, Inc. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -15.46% and closed its last trading session at $5.74. The company has the market capitalization of $1.13 Billion. The stock has 52-week high of $11.26 and 52-Week low of $4.39. The firm touched its 52-Week high on Dec 29, 2015 and 52-Week low on Nov 4, 2016. The company has volume of 17.48 Million shares. The company has a total of 196.57 Million shares outstanding.

TherapeuticsMD, Inc. (NYSEMKT:TXMD) in the last quarter reported its actual EPS of $-0.13/share where the analyst estimated EPS was $-0.11/share. The difference between the actual and Estimated EPS is $-0.02. This shows a surprise factor of -18.2 percent.

The company has YTD performance of -44.65 percent. Beta for TherapeuticsMD, Inc. stands at 1.34 while its ATR (average true range) is 0.45. The company has Weekly Volatility of 8.34%% and Monthly Volatility of 7.63%%.

TherapeuticsMD, Inc. has distance from 20-day Simple Moving Average (SMA20) of -8.74%, Distance from 50-Day Simple Moving Average of -9.98 percent and Distance from 200-Day Simple Moving Average of -20.84%.

The Company currently has ROA (Return on Assets) of -56.2 percent, Return on Equity (ROE) of -60.4 Percent and Return on Investment (ROI) of -135% with Gross margin of 77 percent and Operating & Profit margin of 0% and 0% respectively.

 

SHARE